• Users Online: 37
  • Print this page
  • Email this page


 
 
Table of Contents
CLINICAL IMAGE
Year : 2020  |  Volume : 9  |  Issue : 2  |  Page : 104-105

Magnetic resonance imaging-guided volumetric high-intensity focused ultrasound surgery for pedunculated subserosal uterine leiomyoma


Department of Radiology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam

Date of Submission30-Apr-2019
Date of Decision29-Aug-2019
Date of Acceptance26-Sep-2019
Date of Web Publication28-Apr-2020

Correspondence Address:
Dr. Minh Duc Nguyen
Department of Radiology, Pham Ngoc Thach University of Medicine, 2 Duong Quang Trung, Ward 12, District 10, Ho Chi Minh City
Vietnam
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/GMIT.GMIT_36_19

Get Permissions

  Abstract 


Magnetic resonance imaging-guided volumetric high-intensity focused ultrasound surgery is an innovative nonvascular ablation treatment for uterine leiomyoma. In this clinical image, we aimed to depict one patient with pedunculated subserosal uterine leiomyoma adopting treatment successfully without any complications immediately after treatment and at 6-month follow-up.


How to cite this article:
Nguyen MD. Magnetic resonance imaging-guided volumetric high-intensity focused ultrasound surgery for pedunculated subserosal uterine leiomyoma. Gynecol Minim Invasive Ther 2020;9:104-5

How to cite this URL:
Nguyen MD. Magnetic resonance imaging-guided volumetric high-intensity focused ultrasound surgery for pedunculated subserosal uterine leiomyoma. Gynecol Minim Invasive Ther [serial online] 2020 [cited 2020 May 31];9:104-5. Available from: http://www.e-gmit.com/text.asp?2020/9/2/104/283337



A 42-year-old woman suffered from dominant pelvic tension with transformed symptom severity score (tSSS) of 66 and was indicated magnetic resonance imaging (MRI) for evaluating the uterine leiomyoma features before MRI-guided volumetric high-intensity focused ultrasound (HIFU). MRI results showed that there was a pedunculated subserosal uterine leiomyoma positioned on the anterior wall of the retroverted uterus, and volume of tumor is about 98 ml. Based on T2-signal intensity classification, the uterine leiomyoma was regarded as type I because signal intensity of uterine leiomyoma is less than that of myometrium and equal to that of abdominis rectus muscle [Figure 1]a.[1] Based on T1-quantitative perfusion analysis, the tumor is classified as type A because time signal intensity curve of tumor is lower than that of myometrium. In addition, the Ktrans, Kep, Ve, Vp, and area under the curve of tumor are lower than those of myometrium [Figure 1]b.[2] The serum anti-Müllerian hormone (AMH) before ablation was 2.01 ng/mL. During the treatment time, we avoid sonicating the beam to the tumor tissue nearby the stalk. MRI-guided HIFU produced a nearly complete ablation of tumor with a nonperfused volume ratio of 90%, and 10% remaining alive tissue is adjacent to the stalk [Figure 1]c. At 6-month follow-up, the leiomyoma volume was plunged significantly to 65 ml with the corresponding uterine leiomyoma volume reduction ratio of 33% [Figure 1]d, and tSSS was lessened significantly to 12 with corresponding symptom improvement ratio of 81%. Moreover, the serum AMH was fully preserved.[3] MRI findings at 6-month follow-up manifested that the tumor is still attached to the uterus without any sign of expulsion or torsion.
Figure 1: (a) Sagittal T2-weighted image at screening phase shows a type I pedunculated subserosal uterine leiomyoma located on the anterior wall of retroverted uterus. (b) Axial T1-quantitative perfusion-weighted image at screening phase shows the time signal intensity curve of uterine leiomyoma lower than that of myometrium. (c) Coronal contrast enhancement T1-weighted image after treatment shows near-complete ablation of tumor. (d) Sagittal T2-weighted image at 6-month follow-up shows significant shrinkage of uterine leiomyoma without any sign of stalk detach

Click here to view


Pedunculated subserosal uterine leiomyoma, a special type of subserosal uterine leiomyoma, is formerly regarded as a relative contraindication to some treatments like uterine arterial embolization (UAE) due to the high risk of torsion or expulsion after treatment which will result in severe adverse events such as infection and even shock. Surgery is essential to carry out in serious dilemma. Nonetheless, recent findings recommended that the efficacy and safety of UAE for pedunculated subserosal uterine leiomyoma are proved.[4] In 2004, MRI-guided HIFU achieved the approval from the United States Food and Drug Administration for the treatment of uterine leiomyomas. MRI-guided HIFU is currently evidenced as a minimally invasive ablation method for uterine leiomyomas with effectively safety profile.[1],[2],[3] In this study, MRI-guided HIFU was exploited profitably for pedunculated subserosal uterine leiomyoma without any complications and adverse effects on ovarian reserse. Our findings are in line with previous studies which manifested that MRI-guided HIFU should be taken into consideration as an alternative treatment in company with laparoscopy surgery and UAE.[5],[6]

Ethical approval

Pham Ngoc Thach University of Medicine Institutional Review Board has approved this project, IRB No. 6_CDHA obtained on 22th May in 2015.

Declaration of patient consent

The author certify that he have obtained all appropriate patient consent form. In the form, the patient has given her consent for her images and other clinical information to be reported in the journal. The patient understands that her name and initials will not be published and due efforts will be made to conceal her identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Funaki K, Fukunishi H, Funaki T, Sawada K, Kaji Y, Maruo T, et al. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: Relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol 2007;196:184.e1-6.  Back to cited text no. 1
    
2.
Duc NM, Huy HQ. Effect of magnetic resonance imaging characteristics on uterine fibroid treatment. Rep Med Imaging 2018;11:1-8.  Back to cited text no. 2
    
3.
Lee JS, Hong GY, Lee KH, Kim TE. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid. BJOG 2017;124 Suppl 3:18-22.  Back to cited text no. 3
    
4.
Braude P, Reidy J, Nott V, Taylor A, Forman R. Embolization of uterine leiomyomata: Current concepts in management. Hum Reprod Update 2000;6:603-8.  Back to cited text no. 4
    
5.
Park H, Yoon SW, Kim KA, Jung Kim D, Jung SG. Magnetic resonance imaging-guided focused ultrasound treatment of pedunculated subserosal uterine fibroids: A preliminary report. J Vasc Interv Radiol 2012;23:1589-93.  Back to cited text no. 5
    
6.
Brown DL, Hesley GK, Gorny KR, Stewart EA. Safety of MR-guided focused ultrasound treatment of pedunculated subserosal uterine leiomyomas. J Ther Ultrasound 2013;1:19.  Back to cited text no. 6
    


    Figures

  [Figure 1]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
Abstract
References
Article Figures

 Article Access Statistics
    Viewed80    
    Printed2    
    Emailed0    
    PDF Downloaded18    
    Comments [Add]    

Recommend this journal